Research identifies common neuroimmune signatures in rapid-acting antidepressants
2 sources·Updated July 31, 2026
Covered by 2 sources
- Medical Xpress·10h agoImmune signals may help predict responses to therapies for difficult-to-treat depression
In a new study, researchers from The University of Texas MD Anderson Cancer Center have uncovered insights that may help explain how rapid-acting antidepressants, such as ketamine and psychedelics, can reduce symptoms of difficult-to-treat depression. The findings may also help…
Read at Medical Xpress → - News-Medical·23h agoResearch identifies common neuroimmune signatures in rapid-acting antidepressants
In a new study, researchers from The University of Texas MD Anderson Cancer Center have uncovered insights that may help explain how rapid-acting antidepressants, such as ketamine and psychedelics, can reduce symptoms in difficult-to-treat depression.
Read at News-Medical →